Adaptimmune Therapeutics shares owned by Matrix Capital Management Company
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Matrix Capital Management Company
from 13F filings
Historical chart of Matrix Capital Management Company investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Matrix Capital Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Matrix Capital Management Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $30M | 39M | 0.78 |
| 2023-06-30 | $36M | 39M | 0.93 |
| 2023-03-31 | $43M | 39M | 1.09 |
| 2022-12-31 | $57M | 39M | 1.46 |
| 2022-09-30 | $42M | 39M | 1.08 |
| 2022-06-30 | $66M | 39M | 1.70 |
| 2022-03-31 | $80M | 39M | 2.06 |
| 2021-12-31 | $146M | 39M | 3.75 |
| 2021-09-30 | $202M | 39M | 5.17 |
| 2021-06-30 | $166M | 39M | 4.26 |
| 2021-03-31 | $207M | 39M | 5.31 |
| 2020-12-31 | $210M | 39M | 5.39 |
| 2020-09-30 | $311M | 39M | 7.98 |
| 2020-06-30 | $390M | 39M | 10.01 |
| 2020-03-31 | $94M | 34M | 2.72 |
| 2019-12-31 | $34M | 28M | 1.20 |
| 2019-09-30 | $42M | 28M | 1.51 |
| 2019-06-30 | $113M | 28M | 4.02 |
| 2019-03-31 | $120M | 28M | 4.30 |
| 2018-12-31 | $156M | 27M | 5.75 |
| 2018-09-30 | $276M | 20M | 13.56 |
| 2018-06-30 | $167M | 14M | 11.87 |
| 2018-03-31 | $156M | 14M | 11.23 |
| 2017-12-31 | $82M | 12M | 6.68 |
| 2017-09-30 | $99M | 12M | 8.19 |
| 2017-06-30 | $39M | 8.7M | 4.49 |
More positions owned by Matrix Capital Management Company
View all positions for Matrix Capital Management Company